| Literature DB >> 22545143 |
Maria Giulia Preti1, Francesca Baglio, Maria Marcella Laganà, Ludovica Griffanti, Raffaello Nemni, Mario Clerici, Marco Bozzali, Giuseppe Baselli.
Abstract
Tractography based on Diffusion Tensor Imaging (DTI) represents a valuable tool for investigating brain white matter (WM) microstructure, allowing the computation of damage-related diffusion parameters such as Fractional Anisotropy (FA) in specific WM tracts. This technique appears relevant in the study of pathologies in which brain disconnection plays a major role, such as, for instance, Alzheimer's Disease (AD). Previous DTI studies have reported inconsistent results in defining WM abnormalities in AD and in its prodromal stage (i.e., amnestic Mild Cognitive Impairment; aMCI), especially when investigating the corpus callosum (CC). A reason for these inconsistencies is the use of different processing techniques, which may strongly influence the results. The aim of the current study was to compare a novel atlas-based tractography approach, that sub-divides the CC in eight portions, with Tract-Based Spatial Statistics (TBSS) when used to detect specific patterns of CC FA in AD at different clinical stages. FA data were obtained from 76 subjects (37 with mild AD, 19 with aMCI and 20 elderly healthy controls, HC) and analyzed using both methods. Consistent results were obtained for the two methods, concerning the comparisons AD vs. HC (significantly reduced FA in the whole CC of AD patients) and AD vs. aMCI (significantly reduced FA in the frontal portions of the CC in AD patients), thus identifying a relative preservation of the frontal CC regions in aMCI patients compared to AD. Conversely, the atlas-based method but not the TBSS showed the ability to detect a selective FA change in the CC parietal, left temporal and occipital regions of aMCI patients compared to HC. This finding indicates that an analysis including a higher number of voxels (with no restriction to tract skeletons) may detect characteristic pattern of FA in the CC of patients with preclinical AD, when brain atrophy is still modest.Entities:
Mesh:
Year: 2012 PMID: 22545143 PMCID: PMC3335803 DOI: 10.1371/journal.pone.0035856
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic information of the sample.
| AD (n = 37) | aMCI (n = 19) | HC (n = 20) | |
|
| 75.6±5.1 | 73.2±5.3 | 72±5.3 |
|
| 8.2±3.7 | 10.2±3.6 | 9.1±3.8 |
|
| 17∶20 | 11∶8 | 8∶12 |
|
| 21±3.0 | 27.2±1.4 | 28.7±1.0 |
|
| 1–1.5 | 0–0.5 | 0 |
Demographic information and neuropsychological tests' scores. Chi square was used for gender comparison. One-way ANOVA test with Bonferroni correction for multiple comparisons was used for age, education-year, and MMSE score comparisons (significance level: : pcorr<0.05).
: Significant compared to aMCI and control groups;
: Significant compared to AD group.
Figure 1The probabilistic atlas of the CC divided in eight portions.
CC1: orbital frontal, CC2: anterior frontal, CC3: superior frontal, CC4: superior parietal, CC5: posterior parietal, CC6L: left temporal, CC6R: right temporal, CC7: occipital. In the center, the CC tractographic reconstruction of one healthy subject, to better show the location of the eight portions.
Results of the atlas-based analysis.
| Mean FA (SD) | AD | aMCI | HC | Comparison between groups (p-value) | ||
| AD-HC | aMCI-HC | aMCI-AD | ||||
|
| 0.42 (0.03) | 0.44 (0.03) | 0.47 (0.02) | <0.001 | n.s. | 0.001 |
|
| 0.49 (0.04) | 0.52 (0.04) | 0.55 (0.02) | <0.001 | n.s. | 0.004 |
|
| 0.44 (0.03) | 0.46 (0.03) | 0.49 (0.02) | <0.001 | 0.016 | 0.013 |
|
| 0.44 (0.03) | 0.44 (0.04) | 0.48 (0.03) | <0.001 | 0.001 | n.s. |
|
| 0.53 (0.03) | 0.53 (0.05) | 0.58 (0.02) | <0.001 | 0.004 | n.s. |
|
| 0.68 (0.04) | 0.69 (0.05) | 0.73 (0.01) | <0.001 | 0.022 | n.s. |
|
| 0.59 (0.04) | 0.61 (0.04) | 0.63 (0.02) | <0.001 | n.s. | n.s. |
|
| 0.54 (0.04) | 0.55 (0.04) | 0.60 (0.02) | <0.001 | 0.009 | n.s. |
Comparison between mean FA in the eight CC portions of the three groups of participants (groups 1–3), computed with atlas-based tractography. p-values refer to ANOVA test with correction for multiple comparisons, significance level: pcorr<0.05.
Figure 2Results of the TBSS analysis.
In blue, voxels with pcorr<0.05 are highlighted. a) Comparison HC vs. aMCI; b) Comparison AD vs. aMCI; c) Comparison HC vs. AD. As highlighted by the red circles, in the comparisons a) and c) the FA of the whole CC resulted significantly reduced in AD and aMCI with respect to HC. In case b), instead, FA results significantly reduced in AD compared to aMCI only in the frontal CC regions (CC1–CC2–CC3).
Results of the skeleton-based analysis of the CC.
| Mean FA (SD) | AD | aMCI | HC | Comparison between groups (p-value) | ||
| AD-HC | aMCI-HC | aMCI-AD | ||||
|
| 0.52 (0.05) | 0.56 (0.04) | 0.60 (0.03) | <0.001 | 0.019 | 0.001 |
|
| 0.59 (0.05) | 0.62 (0.04) | 0.65 (0.03) | <0.001 | 0.026 | 0.006 |
|
| 0.55 (0.05) | 0.58 (0.04) | 0.62 (0.03) | <0.001 | 0.01 | 0.007 |
|
| 0.55 (0.04) | 0.56 (0.04) | 0.60 (0.03) | <0.001 | 0.001 | n.s. |
|
| 0.63 (0.04) | 0.64 (0.04) | 0.67 (0.03) | <0.001 | 0.007 | n.s. |
|
| 0.73 (0.04) | 0.73 (0.05) | 0.77 (0.01) | 0.002 | 0.01 | n.s. |
|
| 0.61 (0.04) | 0.63 (0.04) | 0.64 (0.02) | <0.001 | n.s. | n.s. |
|
| 0.65 (0.05) | 0.67 (0.05) | 0.71 (0.02) | <0.001 | 0.005 | n.s. |
Comparison between mean FA computed in the 8 CC skeleton portions of the three groups of participants (groups 1–3). p-values refer to ANOVA test with correction for multiple comparisons, significance level: pcorr<0.05.
Comparison between atlas-based tractography and TBSS in terms of overall percentage of correct pathology detection, sensitivity and specificity.
| Pathology | Method | Overall % | Sensitivity | Specificity |
|
|
| 0.90 | 0.95 | 0.80 |
|
| 0.88 | 0.95 | 0.75 | |
|
|
| 0.82 | 0.79 | 0.85 |
|
| 0.74 | 0.74 | 0.75 | |
|
|
| 0.82 | 0.89 | 0.68 |
|
| 0.79 | 0.84 | 0.68 |
Overall percentage of correct pathology detection, sensitivity and specificity of the two experimented techniques in the detection of AD and aMCI from healthy controls and in the detection of AD from aMCI.
80/20% Cross-validation of the logistic regression model.
| Pathology | Method | Overall % - Selected cases | Overall % - Unselected cases |
|
|
| 0.89 | 0.91 |
|
| 0.86 | 0.87 | |
|
|
| 0.81 | 0.75 |
|
| 0.74 | 0.75 | |
|
|
| 0.85 | 0.78 |
|
| 0.79 | 0.78 |
The overall percentage of correct pathology detection for the validation sample (unselected cases) was always no more than 10% lower than the accuracy rate for the training sample (selected cases), suggesting that the logistic regression model based on this analysis would be effective also applied to cases not included in the sample.